Understanding long-term effects of viral infections like COVID-19.
Project 1
This study is looking to understand how serious diseases like COVID-19, Lassa, and Ebola can impact people's health over time, especially for those who are at risk or have survived these infections, so we can find better ways to help them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11010827 on NIH RePORTER |
What this research studies
This research aims to create a comprehensive dataset to predict how severe diseases like COVID-19, Lassa, and Ebola can affect individuals over time. By examining various factors such as individual health, metabolism, and immune responses, the project seeks to understand who may experience long-term health issues after infection. The study includes participants from both West Africa and the United States, focusing on those at risk or who have survived these viral infections. Advanced technologies and machine learning will be used to identify unique biological markers that indicate persistent disease, which could help in developing better treatments and management strategies.
Who could benefit from this research
Good fit: Ideal candidates include individuals who have been infected with COVID-19, Lassa virus, or Ebola virus, as well as those at risk of these infections.
Not a fit: Patients who have not been infected with these viruses or do not have a history of related health issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved predictions and treatments for patients suffering from long-term effects of viral infections.
How similar studies have performed: Previous research has shown promise in understanding long-term effects of viral infections, making this approach both relevant and potentially impactful.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Garry, Robert F — Scripps Research Institute, the
- Study coordinator: Garry, Robert F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.